Figure 1
From: Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk
Odds ratios and 95% confidence intervals of breast cancer according to bisphosphonate use and body mass index (BMI). Odds ratios were adjusted for age at diagnosis, party, age at first live birth, family history of breast cancer, BMI menopausal status, age at menopause, type of hormone use, mammography, osteoporosis, smoking history, and height change. P-interaction for BMI and use of bisphosphonates=0.005.
